Peter Savas

1.6k total citations
9 papers, 130 citations indexed

About

Peter Savas is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Savas has authored 9 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Savas's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (3 papers) and Advanced Breast Cancer Therapies (2 papers). Peter Savas is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (3 papers) and Advanced Breast Cancer Therapies (2 papers). Peter Savas collaborates with scholars based in Australia, Belgium and Spain. Peter Savas's co-authors include Sherene Loi, Stephen J. Luen, Roberto Salgado, Lironne Wein, Tira J. Tan, Shankar Siva, Rebecca Dent, Steven David, Ingrid A. Mayer and Valentina Boni and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Peter Savas

9 papers receiving 128 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Savas Australia 6 94 52 39 28 18 9 130
Stephen J. Luen Australia 3 108 1.1× 43 0.8× 61 1.6× 21 0.8× 22 1.2× 7 143
Egmidio Medina United States 7 106 1.1× 80 1.5× 64 1.6× 24 0.9× 22 1.2× 10 173
Joanne Leung Canada 5 92 1.0× 103 2.0× 41 1.1× 11 0.4× 14 0.8× 6 157
Kelsey Schwensen United States 4 114 1.2× 36 0.7× 20 0.5× 62 2.2× 35 1.9× 6 150
Oliver Cast United Kingdom 2 44 0.5× 44 0.8× 60 1.5× 40 1.4× 16 0.9× 2 118
André Vanoli France 4 155 1.6× 121 2.3× 17 0.4× 32 1.1× 27 1.5× 6 203
Leena Tiainen Finland 6 63 0.7× 31 0.6× 68 1.7× 26 0.9× 11 0.6× 12 125
Ekaterina Postovalova United States 6 33 0.4× 27 0.5× 27 0.7× 27 1.0× 13 0.7× 25 98
Derya Kabacaoğlu Germany 4 127 1.4× 81 1.6× 59 1.5× 34 1.2× 10 0.6× 5 185
Guillaume Habif France 5 125 1.3× 164 3.2× 34 0.9× 15 0.5× 12 0.7× 6 199

Countries citing papers authored by Peter Savas

Since Specialization
Citations

This map shows the geographic impact of Peter Savas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Savas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Savas more than expected).

Fields of papers citing papers by Peter Savas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Savas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Savas. The network helps show where Peter Savas may publish in the future.

Co-authorship network of co-authors of Peter Savas

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Savas. A scholar is included among the top collaborators of Peter Savas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Savas. Peter Savas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
David, Steven, et al.. (2022). Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions. Biomedicines. 10(4). 821–821. 8 indexed citations
2.
3.
4.
Luen, Stephen J., Gaia Griguolo, Paolo Nucíforo, et al.. (2019). On-treatment changes in tumor-infiltrating lymphocytes (TIL) during neoadjuvant HER2 therapy (NAT) and clinical outcome.. Journal of Clinical Oncology. 37(15_suppl). 574–574. 6 indexed citations
5.
Wein, Lironne, Stephen J. Luen, Peter Savas, Roberto Salgado, & Sherene Loi. (2018). Checkpoint blockade in the treatment of breast cancer: current status and future directions. British Journal of Cancer. 119(1). 4–11. 83 indexed citations
6.
Mayer, Ingrid A., Rebecca Dent, Tira J. Tan, Peter Savas, & Sherene Loi. (2017). Novel Targeted Agents and Immunotherapy in Breast Cancer. American Society of Clinical Oncology Educational Book. 37(37). 65–75. 12 indexed citations
7.
Mooi, Jennifer, Pratyaksha Wirapati, Rebecca Asher, et al.. (2017). Consensus molecular subtypes (cms) as predictors of benefit from bevacizumab in first line treatment of metastatic colorectal cancer: Retrospective analysis of the MAX clinical trial. Annals of Oncology. 28. v160–v161. 1 indexed citations
8.
Tran, Ben, Anne Hamilton, Lisa G. Horvath, et al.. (2016). First-in-man trial of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) as a continuous intravenous infusion (CIVI), in patients (pt) with advanced solid tumours.. Journal of Clinical Oncology. 34(15_suppl). e14025–e14025. 4 indexed citations
9.
Savas, Peter, Roberto Salgado, Franco Caramia, et al.. (2015). Lack of correlation of neoantigens arising from tumor somatic mutations with tumor infiltrating lymphocytes (TILs) or survival in HER2-positive breast cancer (HER2+ BC).. Journal of Clinical Oncology. 33(15_suppl). 613–613. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Luen Breakdown of academic impact, for papers by Egmidio Medina Breakdown of academic impact, for papers by Joanne Leung Breakdown of academic impact, for papers by Kelsey Schwensen Breakdown of academic impact, for papers by Oliver Cast Breakdown of academic impact, for papers by André Vanoli Breakdown of academic impact, for papers by Leena Tiainen Breakdown of academic impact, for papers by Ekaterina Postovalova Breakdown of academic impact, for papers by Derya Kabacaoğlu Breakdown of academic impact, for papers by Guillaume Habif
Rankless by CCL
2026